Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-21

Clinical Trial Update: Telmisartan in Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating telmisartan in prostate cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telmisartan (Telmisartan)

Snippet

Sponsor: Tyler J Curiel | Conditions: Prostate Cancer | Phase 1 | Status: RECRUITING